REC Limited’s revenue in Q3FY23 fell 2% to ₹ 9,782 crores. Consolidated Profit After Tax came at ₹ 2,915 crores showcasing a 5% rise YoY over the corresponding period. In this quarter’s results, the reports suggested that the firm has continued to deliver consistent performance in all key operational and financial indicators in Q3Y23.
REC Limited Q3FY23; 5% Growth in Profits

Tags: Power
Related Post
- Aurobindo Pharma Ltd Q4FY25; 0% fall in Profits
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals…
-
Astral Ltd Q4FY25; 2% fall in Profits
Astral Poly Technik Ltd was established in 1996, with the aim to manufacture pro-India plumbing…
-
Astrazeneca Pharma India Ltd Q4FY25; 3% rise in Revenue
AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of…